Approval · Notice of Compliance 9428 · 2008
FLUNAZINE: Notice of Compliance 9428
Issued March 19, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9428
- Date
- March 19, 2008
- Company
- Bimeda-MTC Animal Health Inc.Cambridge, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- For the control of pyrexia associated with bovine respiratory disease, and the control of pyrexia and inflammation associated with endotoxemia, in beef cattle and non-lactating dairy cattle; alternate source of active ingredient
- Therapeutic class
- Non steroidal anti-inflammatory, antipyretic, analgesic
- Canadian reference product
- BANAMINE (Schering-Plough Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUNAZINE | 02240510 | Marketed |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 50 MG per ML